- Home
- CREG vs SNGX Comparison
CREG vs SNGX Comparison
Compare CREG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- SNGX
- Stock Information
- Founded
- CREG N/A
- SNGX 1987
- Country
- CREG China
- SNGX United States
- Employees
- CREG N/A
- SNGX N/A
- Industry
- CREG Power Generation
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- CREG Utilities
- SNGX Health Care
- Exchange
- CREG Nasdaq
- SNGX Nasdaq
- Market Cap
- CREG 4.7M
- SNGX 4.3M
- IPO Year
- CREG N/A
- SNGX 1987
- Fundamental
- Price
- CREG $1.61
- SNGX $2.98
- Analyst Decision
- CREG
- SNGX Strong Buy
- Analyst Count
- CREG 0
- SNGX 1
- Target Price
- CREG N/A
- SNGX $6.00
- AVG Volume (30 Days)
- CREG 3.8M
- SNGX 12.6M
- Earning Date
- CREG 08-14-2025
- SNGX 08-14-2025
- Dividend Yield
- CREG N/A
- SNGX N/A
- EPS Growth
- CREG N/A
- SNGX N/A
- EPS
- CREG N/A
- SNGX N/A
- Revenue
- CREG $82,839.00
- SNGX N/A
- Revenue This Year
- CREG N/A
- SNGX N/A
- Revenue Next Year
- CREG N/A
- SNGX N/A
- P/E Ratio
- CREG N/A
- SNGX N/A
- Revenue Growth
- CREG N/A
- SNGX N/A
- 52 Week Low
- CREG $1.11
- SNGX $1.09
- 52 Week High
- CREG $14.70
- SNGX $6.23
- Technical
- Relative Strength Index (RSI)
- CREG 44.49
- SNGX 52.95
- Support Level
- CREG $1.11
- SNGX $2.97
- Resistance Level
- CREG $1.69
- SNGX $6.23
- Average True Range (ATR)
- CREG 0.16
- SNGX 0.49
- MACD
- CREG 0.07
- SNGX -0.09
- Stochastic Oscillator
- CREG 75.86
- SNGX 17.34
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).